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Bacterial Disease in Diverse Hosts Minireview
attention has been paid to type III secretion systems,B. Brett Finlay
which specifically transport virulence factors out of bac-Biotechnology Laboratory and
teria, often in response to contacting host cells or hostDepartment of Biochemistry and Molecular Biology
factors (often called ªcontact-mediatedº secretion) (re-Department of Microbiology and Immunology
viewed by Hueck, 1998). Remarkably, type III systemsUniversity of British Columbia
also transport specific virulence factors directly intoVancouver, British Columbia
host cells, acting as a syringe to deliver these factorsCanada V6T 1Z3
into the host cell cytoplasm or membrane. Although the
type III apparatus is conserved, the effector molecules
vary, giving each pathogen the factors needed to cause
Bacteria are capable of causing disease in a myriad of
a specific disease. For example, Salmonella species use
animal and plant hosts. Because of this, bacteria are a type III system to inject a specialized molecule into
responsible for much morbidity and mortality worldwide, epithelial cells that activates the small GTPases Rac-1
in addition to damage to crops and agricultural animals. and CDC42, causing membrane ruffling and bacterial
The ever increasing incidence of antibiotic resistance, uptake into normally nonphagocytic cells (Hardt et al.,
coupled with new and reemerging bacterial pathogens, 1998). In contrast, enteropathogenic and O157:H7 E.
has heightened our awareness of bacterial infectious coli use the type III system to deliver a bacterial molecule
diseases. Each pathogen usually possesses a specific (Tir) into the epithelial cell membrane; Tir then serves
set of virulence factors that have evolved to affect one as the receptor for a bacterial outer membrane protein
or a small number of particular hosts, thereby limiting (intimin) that mediates bacterial binding and cytoskeletal
its host range and the available models to study that rearrangements (Kenny et al., 1997). Yersinia species
disease. On the other hand, hosts have designed spe- inject a tyrosine phosphatase, an actin toxin, a kinase,
cialized strategies to resist such infections, often in re- and other proteins that collectively paralyze the phago-
sponse to these virulence factors or to the damage cytic machinery of macrophages, thereby preventing
caused by them. However, it has recently been shown phagocytosis and clearance of the pathogen (reviewed
that some pathogens have the capacity to produce viru- by Cornelis and Wolfwatz, 1997).
lence factors that cause disease in hosts as diverse as Several new technologies have recently been devel-
plants, nematodes, and mammals (Rahme et al., 1995, oped to identify and further study virulence factors (re-
1997; Mahajan-Miklos et al., 1999; Tan et al., 1999). This viewed by Strauss and Falkow, 1997). New assays have
knowledge provides us with new tools and economical been developed to identify bacterial factors that are
disease models to examine the interplay that occurs induced in an animal infection model (in vivo expression
between a pathogen and its host by manipulating host technology [IVET] and differential fluorescence induc-
factors involved in disease resistance, as well as to tion [DFI]) or are required for survival within an animal
identify and study bacterial virulence factors and poten- (signature tagged mutagenesis [STM]). Coupled with
tial new therapeutics. these new assays are improved technologies to study
Bacterial Virulence Factors the effects of virulence factors on host cells, including
During the past few years, remarkable progress has confocal and digital microscopy, fluorescent activated
been made in the identification and characterization of cell sorting, transfection of virulence factors into host
bacterial virulence factors and their mechanisms that cells, and other cell biology tools. Given that the entire
mediate disease in humans and other animals (reviewed genome sequences of most major human pathogens
by Finlay and Cossart, 1997; Finlay and Falkow, 1997). will be completed by the turn of the century, many of
However, the sophistication of these virulence factors these and other techniques are being exploited to further
and their regulation was unanticipated. Secreted toxins our knowledge about virulence factors.
were some of the first virulence factors identified be- Host Resistance to Disease
cause they were easily purified from bacterial superna- Despite our rapidly increasing understanding of viru-
tants. By manipulating growth conditions to better lence factors, much less is known about how hosts resist
mimic conditions found inside a host, expression of pre- disease and the molecules they use to counter these
viously unidentified virulence factors was achieved, virulence factors. In vertebrates, host resistance is com-
along with the realization that most virulence factors plex and multifactorial (reviewed by Malo and Skamene,
are tightly regulated for production under conditions 1994). Mapping and manipulating host resistance genes
representative of those found within a host. These con- is difficult and requires significant effort. Much of what
ditions include temperature, various ion concentrations, we know comes from genetic susceptibility mapping,
and even the presence of host molecules from serum and in animals, inbreeding for susceptibility and resis-
or cultured cells. tance. Although several host resistance loci have been
Increased knowledge about virulence factors also mapped, the role of these loci is not well characterized.
came from the realization that most virulence factors Perhaps the best studied mammalian resistance marker
are either on the bacterial surface or secreted such that is NRAMP1 (natural resistance-associated macrophage
they can interact with host components. Thus, several protein 1), a mouse lysosomal membrane protein that
secretion pathways were identified that transported vir- is required for resistance to intracellular pathogens such
as Salmonella, Mycobacterium, and Leishmania speciesulence factors out of Gram-negative bacteria. Particular
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(reviewed by Skamene et al., 1998). However, its mecha- is needed to form disulfide bonds in the bacterial peri-
plasm. In addition to gacA, one of the other transposonnism of action remains undetermined.
Our knowledge about plant disease resistance pro- mutants was inserted in a region immediately down-
stream of the pyocyanin biosynthetic operon and af-teins (R factors) and their interactions with specific viru-
lence factors is much more sophisticated than in mam- fected pyocyanin production. This indicated that the
Arabidopsis plant model could be used to identify othermalian models (reviewed by Baker et al., 1997). This
knowledge comes from breeding resistant plants and animal virulence factors.
Nematodes: A Model for Humanfrom the ability to generate mutations in plants and
screen for resistant and susceptible plant hosts. It has Infectious Disease?
Most recently, Ausubel's group have extended the Pseu-become apparent that virulence factors in plant patho-
gens interact with specific plant resistant proteins, and domonas infection model to an unlikely host, the nema-
tode Caenorhabditis elegans (Mahajan-Miklos et al.,that this sophisticated interaction is pathogen specific.
Overlaps between Plant and Animal Pathogens? 1999; Tan et al., 1999). They found that when PA-14 was
grown on low phosphate, high osmolarity medium, andHistorically, it was thought that there was little or no
overlap in virulence factors between animal and plant the lawn used as food for C. elegans, the nematodes
died within 24 hr (ªfast killingº) (Mahajan-Miklos et al.,pathogens due to differences in their respective hosts,
presumably necessitating completely different mecha- 1999). This killing was related to the developmental
stage of the worm, and those at the last larval stagenisms. However, this view suddenly changed when type
III secretion systems were found in plant pathogens, (L4) were much more susceptible than adults. Actual
contact with the bacteria was not needed, since thewhere they are used to secrete bacterial virulence fac-
tors into plant cells to cause disease (reviewed by Van toxic activity was found in agar that was separated from
bacteria by a filter. Once the model was established,Gijsegem et al., 1993). Exciting similarities have been
found between a type III secreted Yersinia effector pro- they screened 3300 TnphoA transposon mutants in PA-
14 for fast killing. Seven attenuated mutants were identi-tein that triggers apoptosis in macrophages and a
homologous type III secreted protein from a plant patho- fied, with four of these producing less pigment (needed
for the blue-green color of P. aeruginosa). This color isgen, Xanthomonas campestris, that induces programmed
cell death in plant cells (Mills et al., 1997; Monack et al., due to the tricyclic secondary metabolites known as
phenazines, including pyocyanin (1-hydroxy-5-methyl-1997). This indicates that even effector proteins might be
similar in plant and animal pathogens. However, doubt phenazine).
The P. aeruginosa genome is nearing completion, andremained whether a particular pathogen could use the
same virulence factors to cause disease in both plants using inverse PCR, they were able to identify the genes
interrupted by the different transposon insertions. In theand animals.
A Pathogen that Infects Both Plants and Animals three mutants that had normal pigment production, the
insertions were in the following: (a) hrpM, a locus thatIn 1995, Rahme et al. published a provocative paper
demonstrating that there are indeed common virulence controls pathogenicity in P. syringae; (b) mexA, which
encodes part of a broad substrate efflux pump; and (c)factors needed to cause disease in plants and animals.
Pseudomonas aeruginosa is an opportunistic human orp, an osmoregulator of phospholipase C. One of the
nonpigmented mutants contained an insertion in a novelpathogen, causing disease in cystic fibrosis patients,
burn victims, and cancer patients. They tested 75 P. predicted two-component regulator, while two others
were in the same gene, phzB, whose product regulatesaeruginosa isolates (30 of which were human isolates)
in an Arabidopsis thaliana leaf infiltrate model and found synthesis of phenazine-1-carboxylate needed in pyocy-
anin production. They further tested the role of phen-two strains that caused severe plant disease in several
Arabidopsis ecotypes, one of which was a human isolate azines by specifically deleting genes (phnA and phnB)
necessary for pyocyanin production and showed that(PA-14). This strain was also fully virulent in a mouse
skin burn model. They created mutations in two known these loci are needed for fast killing of worms, in addition
to being less virulent in plants and animals (see above).animal virulence genes, toxA (which encodes exotoxin
A) and plcS (phospholipase), and one plant virulence This group has also recently examined the process
of slow killing in worms (Tan et al., 1999). They foundgene, gacA, which encodes a transcriptional regulator in
Pseudomonas syringae (a plant pathogen) that controls that slow killing (worm death after several days) involves
an infection-like process and correlates with viable bac-secretion of pyocyanin, a phenazine compound which
is toxic to cells. They found that mutations in all three terial growth in the worm intestines. Different virulence
factors are involved in the two killing mechanisms, indi-virulence factors resulted in a significant reduction in
pathogenicity in both hosts, indicating that these three cating that the two are mechanistically different. They
found that several of the genes involved in pathogenesisloci encode common virulence factors needed for dis-
ease in these diverse hosts. in animals and plants are also needed for slow killing in
nematodes, and they used this system to identify newRahme et al. (1995) hypothesized that with this plant
infection model they should be able to identify additional virulence factors that participate in this infectious-like
process.overlapping virulence factors. They mutagenized PA14
and screened these mutants in the plant leaf model Host Alteration to Determine Mechanism
of Virulenceand found nine mutants that had significantly reduced
virulence (Rahme et al., 1997). Remarkably, all nine of Although many host models have been used to identify
and characterize bacterial virulence factors, it is usuallythese mutants were also attenuated in the mouse burn
model. Of these nine, only two were in previously de- quite difficult, if not impossible, to genetically manipu-
late the host to test various hypotheses about virulencescribed loci: gacA (see above) and dsbA, a locus that
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Figure 1. Pyocyanin-Mediated Fast Killing of C. elegans by P. aeruginosa
Bacteria (blue oval) are ingested by the nematode and produce secreted pyocyanins (white circles). These are toxic to the worm due to the
generation of oxidative stress. The nematode's P glycoprotein pump is capable of removing the toxins, thereby decreasing their toxic effects.
factor mechanisms of action. Mahajan-Miklos et al. of avirulent mutants can then be tested in a mammalian
model. As tools are developed to knock out each reading(1999) describe a model to address this (Figure 1). Pyo-
cyanin is toxic to cells because it is able to generate frame in a pathogen once its genome is sequenced,
there is much interest in screening these mutants in atoxic reactive oxygen species, including superoxide and
hydrogen peroxide. This group tested C. elegans mu- convenient and economical disease model. There are
ever increasing numbers of nematode mutants beingtants that were either more resistant (age-1(hx546)) or
more sensitive (mev-1(kn1) and rad-8(mn163)) to oxida- made, and these mutants could also be screened for
disease following infection. Such screens could be use-tive stress. As expected, they found that resistance or
susceptibility to oxidative stress correlated with resis- ful in identifying host resistance and susceptibility
genes, potentially identifying mammalian homologs andtance or susceptibility to fast killing, indicating that pyo-
cyanin probably mediates its toxic effects through gen- unraveling the complexity of host resistance. Finally,
potential therapeutics could be developed and testederation of reactive oxygen species.
A potential host resistance strategy would be to pump in such a disease model, providing they were verified
in a more relevant infection model.diffusible toxins out of cells. By testing C. elegans mu-
tants lacking P-glycoproteins (ATP-binding transport- Despite the appeal of the nematode model, it is impor-
tant to consider that there are several significant limita-ers), they found that these mutants were much more
sensitive to fast killing. In addition, they observed that tions. Perhaps the most obvious is that C. elegans is not
known to be infected naturally by bacterial pathogens.if PA-14 pyocyanin mutants were used to infect the de-
fective nematode, these worms were no longer sensitive Most mammalian pathogens tightly regulate their viru-
lence factors, being induced only in response to specificto fast killing. They were still susceptible to PA-14 strains
that produced normal levels of pigmentation but were host environments or molecules. Temperature (usually
378C) is a key signal, and one would assume that manydefective in other virulence factors. Collectively, these
results demonstrate that P-glycoproteins play a critical mammalian virulence factors would not be expressed
inside the worm (which is grown at room temperature).role in host defense against the virulence factor pyo-
cyanin. Another major difficulty is the lack of a developed im-
mune system in the nematode, since the role of manyWorms and the Future of Infectious Disease
The significance of the results of Mahajan-Miklos et al. virulence factors is to subvert or neutralize the host
immune response. Thus, although offering an intriguing(1999) lies in the ability to genetically alter both the host
and pathogen and test disease outcome. P. aeruginosa possibility, the universality of this model will need to be
tested.is a relatively easy organism to genetically manipulate.
Its genome is nearly finished, greatly facilitating the iden- Furthermore, it appears that PA-14 is different than
most clinical isolates, and the ability to have such atification and generation of mutants unable to cause
disease in model systems. In addition, C. elegans is also broad host range is an exception, since only a fraction
of P. aeruginosa isolates were found that were highlya good model organism, with much known about its
biology and genome. The combination of these two sys- pathogenic in both plants and animals. Most pathogens
have a very narrow host specificity. For example, S.tems makes this model particularly appealing as we
enter the postgenomic era with both organisms. By typhi, Neisseria gonorrhoeae, and enteropathogenic E.
coli are all human specific, and no animal models existdemonstrating that many of the virulence factors identi-
fied in this model are also needed for disease in animals presumably because some host component (such as a
receptor or other factor) is only found in human hosts.and plants, this model is particularly attractive to screen
for virulence factors. Additionally, it is becoming appar- If host specificity is limited by a single or small number
of factors, it is conceivable that these factors, onceent that the innate immune responses between simpler
organisms (such as Drosophila, and probably C. ele- identified, could be expressed in other model organisms
(such as transgenic mice or even C. elegans) to creategans) and mammalian hosts share several similarities,
indicating that such models might provide tools to study a more susceptible model host.
The ability of PA-14 to infect nematodes, plants, andinnate immunity (reviewed by Hoffman et al., 1996). To
do similar screens in a mouse model would require pro- animals seemingly contradicts much of what we have
learned about the strict regulation and specific mecha-hibitive numbers of animals. Instead, by doing a compre-
hensive screen in the nematode model, a small number nisms of bacterial virulence factors. Although it is an
Cell
318
exception, it can certainly be exploited. Knowing the
potential exists to infect diverse hosts, several other
model organisms (such as flies, zebra fish, etc.) can be
tested for infection with various pathogens. It is likely
that in most cases there will be no disease. However,
if additional host models can be established, these can
certainly be exploited to probe the complex interactions
between pathogens and their hosts, thereby increasing
our knowledge about virulence factors, host resistance
to disease, and the complex interplay that occurs be-
tween them. Ultimately, these models can be used to
assist in the development of new therapeutics to combat
bacterial diseases.
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